C3, Gm, and Pi polymorphisms in rheumatoid arthritis
Thomson, W.; Dyer, P.A.; Sanders, P.A.; Grennan, D.M.
Disease Markers 4(1-2): 145-150
1986
ISSN/ISBN: 0278-0240 PMID: 3133151 Document Number: 268311
This paper reviews the associations between RA and three non-MHS genetic markers: C3, Gm, and Pi. There is no evidence to suggest that genes linked to C3 predispose to RA. However, there is evidence to suggest that genes on chromosome 14, linked to both Gm and Pi, do influence susceptibility to RA and further studies of this chromosome are indicated.
Document emailed within 1 workday
Related Documents
Yun, H-Ryeon.; Lee, S-Ok.; Choi, E.Ju.; Shin, H.Doo.; Jun, J-Bum.; Bae, S-Cheol. 2008: Cyclooxygenase-2 polymorphisms and risk of rheumatoid arthritis in Koreans Journal of Rheumatology 35(5): 763-769Urcelay, E.; Martínez, A.; Mas-Fontao, A.; Peris-Pertusa, A.; Pascual-Salcedo, D.; Balsa, A.; Fernández-Arquero, M.; de la Concha, E. 2005: Osteopontin gene polymorphisms in Spanish patients with rheumatoid arthritis Journal of Rheumatology 32(3): 405-409
Bate, A.S.; Ollier, W.; Grennan, D.M. 1990: Lack of association between DQ A and DX A polymorphisms with rheumatoid arthritis and Felty's syndrome Disease Markers 8(2): 55-57
Huang, J.; Ushiyama, T.; Inoue, K.; Mori, K.; Hukuda, S. 1999: Possible association of CYP17 gene polymorphisms with the onset of rheumatoid arthritis Clinical and Experimental Rheumatology 17(6): 721-724
Baerwald, C.G.; Panayi, G.S.; Lanchbury, J.S. 1997: Corticotropin releasing hormone promoter region polymorphisms in rheumatoid arthritis Journal of Rheumatology 24(1): 215-216
Lo, S.-F.; Huang, C.-M.; Lin, H.-C.; Chen, W.-C.; Tsai, C.-H.; Tsai, F.-J. 2008: Cytokine (IL-6) and chemokine (IL-8) gene polymorphisms among rheumatoid arthritis patients in Taiwan Clinical and Experimental Rheumatology 26(4): 632-637
An, J-dan.; Li, X-yuan.; Yu, J-bo.; Zhao, Y.; Jin, Z-shun. 2012: Association between the eNOS gene polymorphisms and rheumatoid arthritis risk in a northern Chinese population Chinese Medical Journal 125(8): 1496-1499
Gonzalez-Gay, M.A.; Llorca, J.; Palomino-Morales, R.; Gomez-Acebo, I.; Gonzalez-Juanatey, C.; Martin, J. 2009: Influence of nitric oxide synthase gene polymorphisms on the risk of cardiovascular events in rheumatoid arthritis Clinical and Experimental Rheumatology 27(1): 116-119
García-Bermúdez, M.; González-Juanatey, C.; Rodríguez-Rodríguez, L.; Miranda-Filloy, J.A.; Perez-Esteban, S.; Vazquez-Rodriguez, T.R.; Castañeda, S.; Balsa, A.; Fernández-Gutierrez, B.; Llorca, J.; González-Alvaro, I.; Martín, J.; González-Gay, M.A. 2011: Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis Clinical and Experimental Rheumatology 29(4): 681-688
Arman, A.; Yilmaz, B.; Coker, A.; Inanc, N.; Direskeneli, H. 2006: Interleukin-1 receptor antagonist (IL-1RN) and interleukin-1B gene polymorphisms in Turkish patients with rheumatoid arthritis Clinical and Experimental Rheumatology 24(6): 643-648
Henrard, J.C.; Bennett, P.H.; Burch, T.A. 1974: Epidemiology of rheumatoid arthritis. Evaluation of the so-called Rome and new York criteria for the diagnosis of rheumatoid arthritis in a population study Revue du Rhumatisme et des Maladies Osteo-Articulaires 41(11): 675-683
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162
Barrera, P.; Balsa, A.; Alves, H.; Westhovens, R.; Maenaut, K.; Cornélis, F.; Fritz, P.; Bardin, T.; Ceu Maia, M.; Lopes-Vaz, A.; Pascual Salcedo, D.; de la Concha, E.; Radstake, T.; van de Putte, L.B.; Migliorini, P.; Prudhomme, J.F.; Charron, D.; Spyropoulou, M.; Mendes, A.; Spaepen, M.; Martinez, M.; Stavropoulos, C. 2001: Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF) Journal of Rheumatology 28(5): 968-974
Chen, J.R.; Takahashi, M.; Suzuki, M.; Kushida, K.; Miyamoto, S.; Inoue, T. 1998: Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis Journal of Rheumatology 25(12): 2440-2444
Scherler, M. 1978: Poncet--rheumatoid arthritis. Four cases of rheumatoid arthritis treated with tuberculostatics (author's transl1 Therapeutische Umschau. Revue Therapeutique 35(3): 201-206
Yamanaka, H. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. how to use the guideline in the management of rheumatoid arthritis Clinical Calcium 28(5): 607-610
Suzuki, K.; Takeuchi, T. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Towards precision medicine in rheumatoid arthritis Clinical Calcium 28(5): 626-629
Singh, N.; Garg, S.C. 1988: Rheumatoid arthritis presenting as arthritis mutilans with rheumatoid lung Journal of the Indian Medical Association 86(1): 14-15
Yu, C.; Li, M.; Duan, X.; Fang, Y.; Li, Q.; Wu, R.; Liu, S.; Wang, Y.; Wu, Z.; Shi, X.; Jiang, Z.; Wang, Y.; Hsieh, E.D.; Jin, S.; Jiang, N.; Wang, Q.; Zhao, Y.; Tian, X.; Zeng, X. 2018: Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis Clinical and Experimental Rheumatology 36(5): 836-840
Yasuda, S. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice in the use of T cell co-stimulatory inhibitor for patients with rheumatoid arthritis Clinical Calcium 28(5): 668-676